
'The Skin Art Clinic' - A Lucknow-Based Cosmetic Dermatology Clinic Catering to Mumbai's Elite
NewsVoir
Mumbai (Maharashtra) [India], June 13: In a recent press conference held in Mumbai, Dr. Nidhi Singh Tandon, the founder of The Skin Art Clinic, discussed how her Lucknow-based clinic is becoming the preferred destination for skincare, not only in Uttar Pradesh but across India. With the cosmetic dermatology industry traditionally dominated by metropolitan cities like Delhi, Mumbai, and Bangalore, The Skin Art Clinic has managed to carve out a significant presence by offering personalized care, ethical practices, and cutting-edge technology.
The press conference, which was attended by several key media personnel and industry experts, highlighted a unique approach to skincare. A recent survey conducted across major cities like Delhi, Mumbai, and Bangalore by 3EA revealed that The Skin Art Clinic has become the top choice for many patients seeking results-driven treatments. Notably, the clinic has gained significant attention from individuals in Mumbai and Delhi, with many now traveling to Lucknow for treatments that are at par with the best global standards.
Dr. Nidhi Singh Tandon shared her vision behind the clinic and why she has been so successful in attracting patients from across the country, "When I started The Skin Art Clinic, my primary goal was to create a place where patients could receive advanced and holistic skincare, combined with the ethical practices of personalized attention and aftercare," Dr. Nidhi Singh Tandon explained during the press conference.
The clinic stands out for its advanced technology, including Morpheus8 RF Microneedling, ResurFX, IPL Therapy, Venus Freeze, HIFU, and regenerative treatments like PDRN, GFC, and Exosomes. Dr. Nidhi Singh Tandon shared that such technologies have been instrumental in setting the clinic apart. The clinic is the first in Uttar Pradesh, excluding Noida, to introduce Morpheus8, a non-invasive treatment that promotes deep skin remodeling.
When asked, "What inspired you to adopt advanced technologies like Morpheus8 in your clinic?", Dr. Nidhi Singh Tandon replied, "I believe that bringing in advanced technologies is essential for delivering the best results for our patients. Morpheus8, for instance, is one of the most effective treatments for skin tightening and rejuvenation. I adopted it because it's proven to give visible results while minimizing downtime, which is important for today's fast-paced lifestyle."
Further, when asked, "How do you ensure a new technology is truly effective and safe for your patients?" Dr. Nidhi Singh Tandon explained, "We conduct thorough in-clinic trials for every new technology we introduce. We rely on global standards and international validation. Every new treatment undergoes rigorous safety checks before being offered to our patients. Our priority is always patient safety and results."
The clinic's approach to skincare goes beyond just surface-level treatments. Dr. Nidhi Singh Tandon emphasizes a holistic approach that takes into account not just the skin but also a patient's lifestyle, nutrition, and emotional well-being. This has resulted in a loyal patient base who appreciate the personalized care and tailored treatment plans.
Dr. Nidhi Singh Tandon said that the clinic has earned a strong reputation, particularly among celebrities, business leaders, and athletes, who see The Skin Art Clinic as their top choice for skincare. These high-profile clients value privacy and exclusivity.
The clinic's 7-day free follow-up policy is one of the standout features, which is rare in the industry. The Skin Art Clinic also boasts the highest Net Promoter Score (NPS), underscoring its strong referral rates and patient loyalty.
With increasing demand from patients across India, particularly from Uttar Pradesh, Mumbai, Bangalore, and Delhi, The Skin Art Clinic is proving that exceptional skincare doesn't have to come from metro cities. Its cutting-edge technology, personalized care, and ethical practices are setting the clinic apart as a leader in cosmetic dermatology in India.
According to a recent survey conducted by 3EA, The Skin Art Clinic achieved an impressive 72% patient satisfaction rate, surpassing top clinics in Mumbai (67%), Bangalore (64%), and Delhi (58%). These insights were revealed by 3EA during the press conference, underscoring the clinic's growing reputation on a national scale.
Dr. Nidhi Singh Tandon and her team's dedication to innovation and patient care continues to make The Skin Art Clinic the top choice for cosmetic dermatology in Uttar Pradesh and a trusted name across India.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
32 minutes ago
- Business Standard
KKR's exit from JB Chemicals cements its healthcare track record
KKR & Co's ₹11,900 crore ($1.42 billion) exit from JB Chemicals and Pharmaceuticals marks another successful bet in India's fast-growing healthcare sector, underscoring the US-based private equity giant's strong track record in the space. KKR exited JB Chemicals on Sunday. The sale of its 46.39 per cent stake in JB Chemicals to Torrent Pharmaceuticals comes over four years after KKR acquired control of the company in 2020. The exit follows its blockbuster five-time (5x) return in Max Healthcare in 2022, which remains the largest block deal by a private equity firm in India to date, a person familiar with the matter said. In JB Chemicals, the US-based firm made 36 per cent gross internal rate of return in the exit, including sale of part of its stake via block deal early this year. The JB Chemicals deal adds to KKR's expanding healthcare portfolio in India, which includes stakes in Healthcare Global Enterprises, Baby Memorial Hospital (BMH), Healthium Medtech, and Infinx Healthcare, a US-based healthcare technology firm focused on revenue cycle and patient access solutions. Since the start of 2024, KKR's private equity arm has deployed $2 billion in India. In June, the firm arranged $600 million in financing for the Manipal group through KKR Capital Markets. The deal, anchored by KKR's private credit and insurance platforms, is aimed at supporting Manipal's long-term growth strategy. The Manipal group, which operates Manipal Health Enterprises, one of India's largest multispecialty hospital chains, has been active in the M&A (mergers and acquisitions) market. Manipal had in April 2023 sold a significant stake in its hospital business to Singapore's Temasek Holdings in a transaction valued at nearly $2 billion. KKR's back-to-back healthcare bets come amid rising investor appetite for India's healthcare sector, fuelled by growing demand for quality care, rising incomes, and increased insurance penetration. In 2024, healthcare funding saw an 80 per cent rise in deal volumes, with notable activity in medtech and single-specialty hospitals. The IT/ITeS sector deal value grew 300 per cent, driven by major transactions such as Perficient ($3 billion), Altimetrik ($900 million), and GeBBS ($865 million). Single-specialty hospitals saw particular interest, with deal volumes doubling as investors targeted underpenetrated categories such as eyecare, oncology, and IVF, as per a report by Bain & Company.
&w=3840&q=100)

Business Standard
33 minutes ago
- Business Standard
Biological E to make HPV9 vaccine under licensing pact with Recbio
Hyderabad-based vaccine manufacturer Biological E (BE) on Monday announced it has entered a licensing agreement with Chinese pharma firm Jiangsu Recbio Technology Company to produce and commercialise Recbio's nine-valent Human Papillomavirus (HPV9) vaccine for India and global markets. The HPV9 vaccine, designed to protect against nine HPV types linked to cervical, vulvar, vaginal, anal and oropharyngeal cancers, as well as genital warts, is currently in Phase 3 clinical trials in China. As part of the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in UNICEF and PAHO tenders in other markets. Recbio will also provide BE with the drug substance (DS) and transfer the technology to formulate, fill, and package the vaccines. 'It will also include technology transfer for DS production at an appropriate time in the future,' Recbio said in a statement. In India, the estimated number of deaths due to cervical cancer stood at 35,691 in 2023, up from 34,806 in 2022 and 33,938 in 2021, according to a parliamentary response by the Union Health Ministry. Recbio claims that the nine-valent HPV vaccine is effective in preventing around 90 per cent of cervical cancers and 90 per cent of anal and genital warts. Commenting on the collaboration, Mahima Datla, Managing Director at BE, said the partnership aligns with the company's commitment to improve global health by making essential vaccines more accessible and affordable. The collaboration also marks a significant milestone for Recbio in entering the Indian and international markets, highlighting its potential in the innovative vaccine field. Liu Yong, Founder, Chairman and Chief Executive Officer (CEO) of Recbio, added that it will work together with BE to accelerate the launch process of the HPV9 vaccine in India. Following the signing of the technology licence agreement between the two companies, Recbio has begun transferring the necessary technical knowledge, materials, and expertise to BE to produce the HPV9 vaccine. BE is expected to begin large-scale manufacturing of the HPV9 vaccine once the technology transfer is completed. Currently, BE supplies its vaccines to more than 140 countries, and its therapeutic products are sold in India, the US and Europe. It had recently received approval for India's first 14-valent Pneumococcal Conjugate Vaccine.


India Today
an hour ago
- India Today
Family died, no friends: Techie locks self in Mumbai flat, rescued after 3 years
A 55-year-old man from Navi Mumbai was rescued last week after spending over three years locked inside his apartment, completely isolated from the outside world. The man, identified as Anup Kumar Nair, was suffering from severe depression and had voluntarily confined himself due to psychological trauma and a former computer programmer, lived in Gharkool Society in Sector 24, Juinagar. According to social workers from SEAL (Social and Evangelical Association for Love), a Panvel-based NGO, he had not stepped out of his flat for more than three only interaction with the outside world came through food delivery apps, which he used to meet his basic needs. When SEAL's team entered his apartment, they found him living in appalling conditions, surrounded by garbage and suffering from a serious leg infection. Nair's life took a downward turn following a series of personal tragedies — the death of his parents a few years ago and the suicide of his elder brother nearly two decades ago. The emotional toll left him mentally exhausted and increasingly withdrawn. Eventually, he chose to isolate himself completely, disconnecting from friends, neighbours, and society at condition came to light after a concerned resident of the society alerted SEAL about the disturbing state of the flat. The NGO's team responded swiftly, gaining access to the apartment and immediately arranging for medical rarely opened his door and never disposed of garbage,' said Vijay Shibe, Chairman of Gharkool Society.'We tried to help him in small ways and even provided financial assistance when we could. But we knew something was seriously wrong.'Local resident Nikhil Marathe, who was instrumental in alerting authorities, added, 'It's heartbreaking to see someone deteriorate like this in silence. We all need to be more aware of those living alone around us.'Currently, Nair is undergoing treatment and rehabilitation at SEAL Ashram in Panvel. Though still emotionally fragile, doctors and caregivers have reported early signs of improvement in his overall health and mental a brief conversation with his caretakers, Nair said, 'My parents are gone, my brother is gone, and I have no friends left. My health is also not good. So there's no scope for a new beginning.'- EndsMust Watch